Products
B2B Zone
3rd Next-Generation Conjugates Summit
3rd Next-Generation Conjugates Summit
Conferences

3rd Next-Generation Conjugates Summit

By

Hanson Wade

2 Followers
26 Feb 2024 - 28 Feb 2024
Free Registration

Event Details

3rd Next-Generation Conjugates Summit

Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Formats
Traditional ADCs have seen significant success in recent years, but still face many challenges, from limited payload capacities to significant toxicities.

Given these limitations, drug developers are venturing beyond the conventional boundaries of conjugate drug design, by exploring novel payloads and targeting formats, with companies including VincerX Pharma, Dyne Therapeutics, and Orum Therapeutics currently awaiting clinical validation.

Join 150+ of your peers to share learnings and collaborate on novel design concepts, key translational and clinical development challenges, and address challenging CMC roadblocks for the next generation of conjugated therapeutics, including antibody-oligonucleotide conjugates, fragment-drug conjugates, antibody-degrader conjugates, small molecule-drug conjugates, and bispecific-drug conjugates and more!


URLs:
Website: https://go.evvnt.com/2049241-0?pid=10018
Tickets: https://go.evvnt.com/2049241-2?pid=10018
Brochure: https://go.evvnt.com/2049241-3?pid=10018

Prices:
Drug Developer Pricing - Conference Only: USD 2999.00,
Drug Developer Pricing - Conference + Pre Conference Day: USD 4197.00,
Solution Provider - Conference Only: USD 3699.00,
Solution Provider - Conference + Pre-Conference Day: USD 5097.00,
Academic Pricing - Conference Only: USD 2599.00,
Academic Pricing - Conference + Pre-Conference Day: USD 3597.00

Speakers: Amy Han, Executive Director, R AND D Chemistry, Regeneron, Bin Wu, Principal Scientist, Amgen Inc., Chad Miller, Co-Founder and Head of Research, Nosis Biosciences, Charles Chen, Senior Director - Clinical Pharmacology and Translational Sciences, Zymeworks, Christian Marsolais, Senior Vice President and Chief Medical Officer, Theratechnologies Inc., Colby Souders, Chief Scientific Officer, BrickBio, Emily Wyent, Senior Director - Research and Development, Dantari, Inc., Graham Cotton, Vice President and Head of Protein Therapeutics, Almac, Gregory Adams, Chief Scientific Officer, Elucida Oncology Inc., Guitao Wang, VP, Coherent Biopharma, Hamid Samareh Afsari, Reagents-Biochemistry And Conjugation Group Lead, Boehringer Ingelheim, Han Kim, In Vivo Pharmacology, Bolt Biotherapeutics, Igor Sherman, Chief Executive Officer and Founder, Alpha Cancer Technologies, Jamie Rich, Senior Director, Technology, Zymeworks, Jan Van Bodegom, Chief Medical Officer, Coretag, Jun Shao, Chief Operating Officer, Zhejiang Hisun Biomaterials Co,Ltd, Lara McGrath, Director - Translational Medicine, AstraZeneca, Leo Marx, Medicinal Chemist and Bioconjugation Manager, Debiopharm Research and Manufacturing SA, Mahendra Deonarain, Chief Executive Officer, Antikor, Mano Manoharan, Senior Vice President, Innovation Chemistry and Alnylam Distinguished Scientist, Alnylam Pharmaceuticals, Marc Damelin, Vice President - Biology, Mersana Therapeutics, Mark Frigerio, Vice President - Chemistry, Bicycle Therapeutics, Melanie Frigault Vice President, Translational Medicine, Vincerx Pharma, Merle Fuchs, Chief Executive Officer and Co-Founder, PRAMOMOLECULAR GmbH, Nathan Tumey, Associate Professor, Binghampton University, Neil Bander, CSO, Convergent Therapeutics, Nicholas Yoder, Senior Director, Platform Development, Dyne Therapeutics, Philipp Spycher, Chief Scientific Officer, Araris Biotech AG, Shalom Goldberg, Senior Principal Scientist, Johnson and Johnson Services, Inc, Stefano Zanotti, Vice President and Head of Neuromuscular Research, Dyne Therapeutics, Vicky Appleman, Principal Scientist, Takeda Pharmaceutical Co. Ltd., Vimal Patel, Vice President, CMC, RadioPharm Theranostics, Xiaoyong, Lu Director, Eli Lilly and Co.

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
08:30 AM - 05:00 PM (Feb 26, Feb 27, Feb 28) (Public)

Speakers

Amy Han
Amy Han
Executive Director, R AND D Chemistry, Regeneron
Bin Wu
Bin Wu
Principal Scientist, Amgen Inc.
Chad Miller
Chad Miller
Co-Founder and Head of Research, Nosis Biosciences
Charles Chen
Charles Chen
Senior Director - Clinical Pharmacology and Translational Sciences, Zymeworks

Comments on 3rd Next-Generation Conjugates Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hotel Commonwealth
500 Commonwealth Avenue ,
Boston 02215, Massachusetts, United States
Official Link :

More Events By Organizer

2nd ADC Analytical Development Summit  2024
2nd ADC Analytical Development Summit  2024
25
Apr
2024
Free
Conferences
3rd Annual LNP Formulation and Process Development Summit
3rd Annual LNP Formulation and Process Development Summit
29
Apr
2024
Free
Conferences
2nd Annual mRNA Process Development and Manufacturing Summit Europe
2nd Annual mRNA Process Development and Manufacturing Summit Europe
23
Apr
2024
3rd Next Generation RNA Therapeutics Summit | May 7-9,, 2024 | Boston, MA
3rd Next Generation RNA Therapeutics Summit | May 7-9,, 2024 | Boston, MA
07
May
2024
LEAP TA Construction 2024
LEAP TA Construction 2024
06
May
2024

LEAP TA Construction 2024

Chicago, United States
Free
Conferences
Advancing Data Center Construction West 2024
Advancing Data Center Construction West 2024
06
May
2024

Advancing Data Center Construction West 2024

Salt Lake County, United States
Free
Conferences

Similar Events

7th Commercializing Continuous Processing in Pharma Summit (CCP)
7th Commercializing Continuous Processing in Pharma Summit (CCP)
07
Mar
2023
3rd Gene Therapy Comparability Summit
3rd Gene Therapy Comparability Summit
28
Mar
2024
Free
Conferences
2nd ADC Analytical Development Summit  2024
2nd ADC Analytical Development Summit  2024
25
Apr
2024
Free
Conferences
Viral Vector Formulation and Process Development Summit Europe
Viral Vector Formulation and Process Development Summit Europe
30
Aug
2023
Free
Conferences
2nd Cell Therapy Analytical Development Summit Europe
2nd Cell Therapy Analytical Development Summit Europe
19
Sep
2023
Free
Conferences
4th Commercializing Flow Chemistry Summit | October 16-18 | Boston, MA
4th Commercializing Flow Chemistry Summit | October 16-18 | Boston, MA
16
Oct
2023
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People